These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 25270426

  • 1. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
    Luciano JV, D'Amico F, Cerdà-Lafont M, Peñarrubia-María MT, Knapp M, Cuesta-Vargas AI, Serrano-Blanco A, García-Campayo J.
    Arthritis Res Ther; 2014 Oct 01; 16(5):451. PubMed ID: 25270426
    [Abstract] [Full Text] [Related]

  • 2. Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).
    Luciano JV, D'Amico F, Feliu-Soler A, McCracken LM, Aguado J, Peñarrubia-María MT, Knapp M, Serrano-Blanco A, García-Campayo J.
    J Pain; 2017 Jul 01; 18(7):868-880. PubMed ID: 28342891
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: a randomised controlled trial.
    Alda M, Luciano JV, Andrés E, Serrano-Blanco A, Rodero B, del Hoyo YL, Roca M, Moreno S, Magallón R, García-Campayo J.
    Arthritis Res Ther; 2011 Jul 01; 13(5):R173. PubMed ID: 22018333
    [Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E, Richards S, Bowrin K, Watson P, Lloyd A, Sadosky A, Zlateva G.
    Curr Med Res Opin; 2010 Apr 01; 26(4):965-75. PubMed ID: 20178405
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
    García-Campayo J, Serrano-Blanco A, Rodero B, Magallón R, Alda M, Andrés E, Luciano JV, del Hoyo YL.
    Trials; 2009 Apr 23; 10():24. PubMed ID: 19389246
    [Abstract] [Full Text] [Related]

  • 6. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, Mannix K, Gola A, Davis S, Wood J, Jones L.
    Health Technol Assess; 2019 May 23; 23(19):1-106. PubMed ID: 31097078
    [Abstract] [Full Text] [Related]

  • 7. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
    Bellows BK, Dahal A, Jiao T, Biskupiak J.
    J Pain Palliat Care Pharmacother; 2012 Jun 23; 26(2):153-64. PubMed ID: 22509775
    [Abstract] [Full Text] [Related]

  • 8. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S, Almeida C, Ambler N, Blair PS, Choy E, Dures E, Hammond A, Hollingworth W, Kadir B, Kirwan J, Plummer Z, Rooke C, Thorn J, Turner N, Pollock J.
    Health Technol Assess; 2019 Oct 23; 23(57):1-130. PubMed ID: 31601357
    [Abstract] [Full Text] [Related]

  • 9. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.
    De Salas-Cansado M, Álvarez E, Olivares JM, Carrasco JL, Ferro MB, Rejas J.
    Soc Psychiatry Psychiatr Epidemiol; 2013 Jun 23; 48(6):985-96. PubMed ID: 23086587
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study).
    Luciano JV, Guallar JA, Aguado J, López-Del-Hoyo Y, Olivan B, Magallón R, Alda M, Serrano-Blanco A, Gili M, Garcia-Campayo J.
    Pain; 2014 Apr 23; 155(4):693-702. PubMed ID: 24378880
    [Abstract] [Full Text] [Related]

  • 11. A systematic review of pharmacoeconomic studies for pregabalin.
    Parker L, Huelin R, Khankhel Z, Wasiak R, Mould J.
    Pain Pract; 2015 Jan 23; 15(1):82-94. PubMed ID: 24815038
    [Abstract] [Full Text] [Related]

  • 12. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, Norrie J, Hudson J, Bowe S, French P, Hutton P, Byrne R, Syrett S, Dudley R, McLeod HJ, Griffiths H, Barnes TR, Davies L, Shields G, Buck D, Tully S, Kingdon D.
    Health Technol Assess; 2019 Feb 23; 23(7):1-144. PubMed ID: 30806619
    [Abstract] [Full Text] [Related]

  • 13. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M, Tai KS, Chandran A, Zlateva G, Leslie D.
    J Med Econ; 2012 Feb 23; 15(1):19-31. PubMed ID: 21970699
    [Abstract] [Full Text] [Related]

  • 14. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, McCrone P, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Health Technol Assess; 2019 Apr 23; 23(17):1-154. PubMed ID: 31042143
    [Abstract] [Full Text] [Related]

  • 15. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J, Margolis J, Cao Z, Fowler R, Sanchez RJ, Mardekian J, Silverman SL.
    Pain Pract; 2011 Apr 23; 11(3):217-29. PubMed ID: 21199319
    [Abstract] [Full Text] [Related]

  • 16. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP, Sanchez RJ, Joshi AV, Cappelleri JC, Kulakodlu M, Halpern R.
    Pain Pract; 2012 Jan 23; 12(1):14-22. PubMed ID: 21615857
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.
    Arreola Ornelas H, Rosado Buzzo A, García L, Dorantes Aguilar J, Contreras Hernández I, Mould Quevedo JF.
    Reumatol Clin; 2012 Jan 23; 8(3):120-7. PubMed ID: 22386298
    [Abstract] [Full Text] [Related]

  • 18. Cost-utility of an 8-month aquatic training for women with fibromyalgia: a randomized controlled trial.
    Gusi N, Tomas-Carus P.
    Arthritis Res Ther; 2008 Jan 23; 10(1):R24. PubMed ID: 18294367
    [Abstract] [Full Text] [Related]

  • 19. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
    O'Connor AB, Noyes K, Holloway RG.
    Pharmacoeconomics; 2008 Jan 23; 26(12):1045-64. PubMed ID: 19014205
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial.
    Witlox M, Kraaij V, Garnefski N, Bohlmeijer E, Smit F, Spinhoven P.
    PLoS One; 2022 Jan 23; 17(1):e0262220. PubMed ID: 35081130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.